14 Jun 2024

Press & news

FluoGuide develops surgical solutions that is expected to reduce suffering for the patient and increases the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

Chief Development Officer (CDO) Grethe Nørskov Rasmussen sells shares


December 9, 2023

Copenhagen, Denmark, 9 December 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) today announces that Grethe Nørskov Rasmussen (CDO) has sold shares.

Member of the Executive Management Grethe Nørskov Rasmussen has sold 30,000 shares in the Company at an average share price of SEK 66.494.

After the sale Grethe holds 343,185 shares in the Company corresponding to 2.79% of the votes and capital.